Skip to content

Clinical trials

Choroidal Neovascularization trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Country / region: Belgium Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20121
20132
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Novartis2
GlaxoSmithKline1
Ophthotech Corporation1
Pfizer1
Quark Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization9
Macular Degeneration8
Geographic Atrophy2
Vision Disorders2
Wet Macular Degeneration2
Diabetic Retinopathy1
Eye Diseases1
Retinal Degeneration1
Retinal Diseases1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.